SCHEDULE 13G/A: Baillie Gifford & Co. Reduces Stake in NEOGEN CORP to 4.5%

Investment manager Baillie Gifford & Co. has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of NEOGEN CORP common stock to 4.5% as of December 31, 2024.

Summary

• Baillie Gifford & Co., a UK-based investment adviser, has filed an Amendment No. 1 to its Schedule 13G for NEOGEN CORP.
• As of December 31, 2024, Baillie Gifford & Co. beneficially owns 9,749,003 shares of NEOGEN CORP common stock.
• This represents 4.5% of the class of securities, indicating a reduction from a previous holding that would have been above 5%.
• Baillie Gifford & Co. holds sole voting power over 7,578,047 shares and sole dispositive power over 9,749,003 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a significant institutional investor, Baillie Gifford & Co., reducing its stake in NEOGEN CORP below the 5% threshold, which can be interpreted as a decrease in confidence or a strategic reallocation of funds.

Positives

• Baillie Gifford & Co. continues to hold a substantial stake of 4.5% in NEOGEN CORP, indicating continued, albeit reduced, investment.

Negatives

• Baillie Gifford & Co. has reduced its beneficial ownership in NEOGEN CORP to 4.5%, falling below the 5% threshold that typically triggers initial Schedule 13G filings, suggesting a partial divestment.

Risks

• The reduction in stake by a significant institutional investor like Baillie Gifford & Co. could be interpreted by the market as a decrease in confidence in NEOGEN CORP's future prospects.
• Such a reduction might lead to negative market sentiment and potential downward pressure on the stock price.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Existing shareholders might view the reduction in stake by a major institutional investor negatively, potentially leading to concerns about the company's future performance or valuation.
• Potential Investors: New investors might be deterred by the news of a large institutional investor reducing its position, prompting further due diligence.

Key Dates

Keywords

NEOGEN CORP, Baillie Gifford & Co., Schedule 13G, beneficial ownership, common stock, institutional investor, stake reduction, investment adviser